Technologies being showcased include a diabetes management app, a hand-held device to detect atrial fibrillation, and a smart navigation system to help the blind
Dubai, United Arab Emirates: The world’s most creative and forward-thinking healthcare start-ups and SMEs have been taking part in the daily inaugural Innov8 Talks at Arab Health 2019.
Thirty two companies from around the world have been invited to present their ideas to an esteemed panel of judges that are involved in driving innovation in the Middle East & North Africa (MENA) region, and will include the world's only closed system for digital point-of-care urine testing – with the system launching at Arab Health - and Virtual Reality (VR) therapy for the home treatment of eye problems, amongst others.
On each of the four days of Arab Health, which continues until 31st January at the Dubai World Trade Centre, eight companies have eight minutes to make their “pitch” for their healthcare innovation in a bid to be selected as a winning pitch and have a potential to shape the future of healthcare.
Commenting on the Arab Health Innov8 Talks, Ross Williams, Exhibition Director, Arab Health, said: “With the digital health start-ups industry said to be worth around $11.5 billion in 2017, the Innov8 Talks are an important platform to highlight the vital role that start-ups and SME’s play in areas such as personalised medicine and technology-enabled care models. So far we’ve seen some amazing technology being presented including an app to detect atrial fibrillation and a hand-held device for the early detection of breast cancer.”
MirambeauAppCare was one of the eight companies that participated in the Innov8 Talks pitch presentations today, showcasing its diabetes management application. DiabiLive is a multiplatform medical application for diabetic patients allowing them greater autonomy by calculating the exact needed insulin dose based on medical protocol, diet and physical activity.
According to Nicolas Babin, Co-founder, MirambeauAppCare: “We decided to participate in the Innov8 Talks pitch at Arab Health because it is a fantastic opportunity to showcase our very innovative diabetes management solution. Last year we won the CES innovation award in Las Vegas so we want to see how our product is perceived at the biggest healthcare show in the region.”
The panel of judges for Innov8 Talks pitch presentations include Dr Mohammad Al Redha, Director, The Executive Office for Organizational Transformation, Dubai Health Authority; Mohamed Hamdy, Head of Venture Capital, Dubai Future Foundation; Saqr AlHemeiri, Chief Innovation Officer, Ministry of Health and Prevention; Mubaraka Ibrahim, Director of IT Department, Ministry of Health and Prevention; Marwan Abdulaziz, Executive Director, Dubai Science Park; Daniel Amir Raduan, Head of Digital Health, Etisalat; as well as Akbar Moideen Thumbay, VP – Healthcare Division, Thumbay Group.
In addition to the pitch presentations, each day of the Innov8 Talks is opened by a keynote speaker discussing topics ranging from genomics, Artificial Intelligence (AI) and the digital transformation of healthcare systems. During the afternoon sessions, the audience will hear from regional and international leaders in the field on how the latest healthcare innovations determined to enhance the delivery of care for patients.
Today, speaking under the theme of disease prevention and management, Sarper Tanli, Group CEO, Manzil Healthcare Services, discussed the transformation of healthcare delivery through translational innovation: “Each year, millions of people around the world enter their peak years of chronic disease and are set to become an unprecedented driver of healthcare costs. The innovation in digital health has enabled a transformation in the delivery of care, putting patients at the centre of care and personalising a host of services that address their unique needs, and preferences to manage chronic diseases.”
Organised by Informa Exhibitions – Healthcare, Arab Health 2019 will welcome more than 4,150 exhibiting companies from 66 countries and an anticipated 84,500+ attendees from across the globe. As well as providing a platform for the world’s leading manufacturers, wholesalers and distributors to meet the medical and scientific community in the Middle East, delegates can benefit from 11 business and Continuing Medical Education (CME) conferences as part of the Arab Health Congress.
About Arab Health
Arab Health is the largest healthcare event in the Middle East and is organised by Informa Exhibitions-Healthcare. Established 44 years ago, Arab Health provides a platform for the world’s leading manufacturers, wholesalers and distributors to meet the medical and scientific community in the Middle East and subcontinent. The 2019 edition of the event is expected to welcome more than 4,150 exhibiting companies and 84,500+ attendees from 160+ countries.
The Arab Health Congress is reputed for delivering the highest quality programme of Continuing Medical Education (CME) to medical professionals in the region. Attended by more than 4,500 delegates from around the globe, 11 conferences will bring a global appeal with international speakers covering a broad spectrum of medical specialities and disciplines.
Arab Health 2019 will take place from 28 – 31 January 2019, at the Dubai World Trade Centre, Dubai, United Arab Emirates.
Twitter: @Arab_Health #ArabHealth
Linkedin: Arab Health Forum
2019 video: https://youtu.be/YmDSVdPG8ZY
Tel: +971 4 365 2711 | Mobile: +971 50 153 6544
Office 106, Arjaan Office Tower, Dubai Media City
PO Box 502701 | Dubai, United Arab Emirates
Website: www.shamalcomms.com© Press Release 2019
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.